InvestorsHub Logo
Followers 16
Posts 1568
Boards Moderated 0
Alias Born 07/07/2015

Re: ralphey post# 112845

Thursday, 08/24/2017 3:18:41 PM

Thursday, August 24, 2017 3:18:41 PM

Post# of 427247
I'll defer to a real MD opinion, but if R-I is successful and Vascepa has FDA label for treatment of CVD on the basis of the R-I trial, then drs & insurance companies would substitute OTC DS for patients with diseases that are specified on the label? Is that what you are saying?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News